WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013055073) OPHTHALMIC COMPOSITION CONTAINING CYCLOSPORINE AND METHOD FOR PREPARING SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/055073    International Application No.:    PCT/KR2012/008160
Publication Date: 18.04.2013 International Filing Date: 09.10.2012
IPC:
A61K 38/13 (2006.01), A61K 9/08 (2006.01), A61P 27/02 (2006.01)
Applicants: KIM, Yong Nam [KR/KR]; (KR)
Inventors: KIM, Yong Nam; (KR)
Agent: CHOI, Kyu Pal; Halla Classic Building 4F. 824-11, Yeoksam-dong Kangnam-gu Seoul 135-080 (KR)
Priority Data:
10-2011-0102909 10.10.2011 KR
Title (EN) OPHTHALMIC COMPOSITION CONTAINING CYCLOSPORINE AND METHOD FOR PREPARING SAME
(FR) COMPOSITION OPHTALMIQUE CONTENANT DE LA CYCLOSPORINE ET SON PROCÉDÉ DE PRÉPARATION
(KO) 사이클로스포린 함유 안약 조성물 및 그 제조방법
Abstract: front page image
(EN)The present invention relates to an ophthalmic composition containing cyclosporine as an active ingredient and comprising propylene glycol, a surfactant, and purified water, and to a method for preparing same. The ophthalmic composition according to the present invention is in the form of a clear and transparent solution, and increases patient compliance due to the absence of side effects, such as cloudy vision or a scorching sensation, and has a high bioavailability due to improved cyclosporine absorbance in the ocular tissue, which is the target organ.
(FR)La présente invention concerne une composition ophtalmique contenant de la cyclosporine comme principe actif et comprenant du propylène glycol, un tensio-actif et de l'eau purifiée, et un procédé pour sa préparation. La composition ophtalmique selon la présente invention est sous la forme d'une solution claire et transparente et améliore l'observance du traitement par un patient en raison de l'absence d'effets secondaires, tels que la vision trouble ou une sensation de brûlure, et a une biodisponibilité élevée en raison de l'absorbance de cyclosporine améliorée dans le tissu oculaire, qui est l'organe cible.
(KO)본 발명은 유효성분으로 사이클로스포린을 함유하며, 프로필렌글리콜, 계면활성제 및 정제수를 포함하는 안약 조성물 및 그 제조방법에 관한 것으로, 본 발명의 안약 조성물은 맑고 투명한 용액형태로서, 시야 흐림, 작열감 등의 부작용이 없어 환자의 복약순응도가 증대되고, 표적 기관인 안구조직으로의 사이클로스포린의 흡수가 개선되어 생체 이용성이 높다.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Korean (KO)
Filing Language: Korean (KO)